Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer

Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement in node-positive breast cancer patients but the optimal dose schedule has still remained undetermined. Objectives. The feasibility of dose-dense epirubicin in combination with cyclophosphamide (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mirzaei, Hamid Reza, Nasrollahi, Fatemeh, Mohammadi Yeganeh, Ladan, Jafari Naeini, Sepideh, Bikdeli, Pegah, Hajian, Parastoo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4172875/
https://ncbi.nlm.nih.gov/pubmed/25276426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/259312
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados